tenk.fyi

Olema Pharmaceuticals, Inc.

OLMANasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$162.5M

25.5% YoY

EPS

$-1.87

15.0% YoY

Cash

$48.3M

65.4% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade